CE Credit | Hepatitis C Online | 7 | Ledipasvir-sofosbuvir (Harvoni)

Objectives for Learning Outcomes

  1. Discuss the treatment indications and appropriate treatment duration when using Ledipasvir-sofosbuvir (Harvoni) for chronic hepatitis C infection. 
  2. Summarize key findings from the ION-1, ION-2, and ION-3 trials.

Additional Information

Format: 
CE Certificate Only
Course summary
Maximum credit available: 
  • 0.50 Contact hours
  • 0.00 Pharmacology hours at the advanced practice level
Available: 
02/11/2017
Expires: 
02/11/2020

Robert G. Gish, MD

Senior Medical Director, St Josephs Hospital and Medical Center, Liver Program, Phoenix, Arizona
Clinical Professor of Medicine, University of Nevada, Las Vegas

Available Credit

  • 0.50 Contact hours
  • 0.00 Pharmacology hours at the advanced practice level
Please login or create account to take this course.